title: Amino-terminal pro-C-type natriuretic peptide in heart failure.
abstract: The levels and pathophysiological role of amino terminal C-type natriuretic peptide in heart failure are unknown. The potential of plasma amino-terminal C-type natriuretic peptide (N-CNP) as a marker of cardiac function was investigated in symptomatic patients. In 305 patients with recent-onset dyspnea and/or peripheral edema, presenting to primary care, assay of plasma amino-terminal C-type natriuretic peptide and other plasma vasoactive hormones was conducted together with echocardiography. Heart failure was diagnosed in 77 (of the 305) patients by rigorous application of predefined criteria. Plasma amino-terminal C-type natriuretic peptide concentrations were elevated in patients with heart failure, and by univariate analysis were related to age, renal function, and other hormones. On multivariate analysis, tertile of plasma N-CNP interacted with tertile of plasma amino-terminal B-type natriuretic peptide to predict heart failure independent of age, gender, renal function, or echocardiographic left ventricular fractional shortening. N-CNP showed significant relations to concurrent plasma CNP, atrial natriuretic peptide (ANP), N-ANP, B-type (or brain) natriuretic peptide (BNP), N-BNP, endothelin-1, and adrenomedullin but not to echocardiographic indicators of left ventricular systolic function. Plasma amino-terminal C-type natriuretic peptide is elevated in heart failure and is related to other plasma hormones in heart failure. These findings suggest a possible compensatory response from the peripheral vasculature to heart failure by an endothelium-based vasodilator peptide and mandate further exploration of the role of C-type natriuretic peptide in this condition.
authors.affiliation: Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, New Zealand.
authors.forename: Sue P
authors.initials: SP
authors.lastname: Wright
authors.forename: Tim C R
authors.initials: TC
authors.lastname: Prickett
authors.forename: Robert N
authors.initials: RN
authors.lastname: Doughty
authors.forename: Chris
authors.initials: C
authors.lastname: Frampton
authors.forename: Greg D
authors.initials: GD
authors.lastname: Gamble
authors.forename: Tim G
authors.initials: TG
authors.lastname: Yandle
authors.forename: Norman
authors.initials: N
authors.lastname: Sharpe
authors.forename: Mark
authors.initials: M
authors.lastname: Richards
mesh_terms: D000328:Adult; D000368:Aged; D015415:Biomarkers / Q000097:blood; D005260:Female; D006333:Heart Failure / Q000175:diagnosis* / Q000000981:diagnostic imaging; D006801:Humans; D008297:Male; D008875:Middle Aged; D020098:Natriuretic Peptide, C-Type / Q000097:blood*; D018377:Neurotransmitter Agents / Q000097:blood; D011498:Protein Precursors / Q000097:blood; D014463:Ultrasonography
chemical_list: D015415:Biomarkers; D018377:Neurotransmitter Agents; D011498:Protein Precursors; C480579:amino-terminal pro-C-type natriuretic peptide, human; D020098:Natriuretic Peptide, C-Type